MKSAPĀ® 19 Audio Companion Part B 
Harvard The Comprehensive 2022 Gastroenterology Update 
Kaplan USMLE Step 2 Qbank 2021 ā Specialty-wise version (PDF) 
At a time when our diabetes knowledge and treatment options have advanced so much, why do clinical outcomes remain suboptimal, with so many patients unable to achieve good control of their disease?
The answer is rooted in three challenges:
- Keeping pace with rapidly advancing options for diabetes care
- Accounting for a patientās unique biological, psychological, social, financial, educational, and cultural factors
- Overcoming structural healthcare barriers that require clinical strategies to fit within a particular mold
This course is designed to equip clinicians to meet these challenges in order to provide evidence-based, optimal care to their patients.
PROGRAM HIGHLIGHTS
This program affords you the opportunity to learn from leaders in the field of diabetes who are distinguished for their outstanding teaching, knowledge, and innovations in clinical care.
- Expert guidance to design comprehensive treatment programs (non-pharmacological and pharmacological) for patients with diabetes
- Guidance to account for biological, psychological, emotional, social, financial and cultural factors that impact the development and progression of diabetes
- The newest data on the identification of different types of diabetes
- The latest scientific information on how to reduce cardiovascular and renal disease risk in patients with type 2 diabetes
- New guidelines and practice recommendations for nutrition and physical activity
- Deep dive into the current nutritional controversies in diabetes care
- Thorough review of current anti-diabetes medications
- How to navigate the recent and controversial data related to some anti-diabetes medications
- New technologies in diabetes care: updates and implications for day-to-day care
- Research breakthroughs
- Best practices that drive more effective treatment plans
- Tips and tricks for navigating barriers within healthcare systems
- Strategies to assess and improve low adherence to therapy
- Medical vs. surgical management of obesity
Who Should Attend
- PHYSICIANS, NPs, RNs, PAs,Ā PHARMACISTS in the fields of :
- Internal Medicine
- Family Medicine
- Geriatric Medicine
- Endocrinology
Schedule
Wednesday, May 04, 2022
| 9:30amĀ toĀ 9:45am | Welcome and IntroductionA. Enrique Caballero, MD, Melinda D. Maryniuk, MEd, RDN, CDCES, FADA |
Special Lecture
| 9:45amĀ toĀ 10:15am | Exciting Advances in Diabetes Care, Yet Poor Outcomes in Most Patients: Why?A. Enrique Caballero, MD |
Identifying Various Types of Diabetes in Clinical Practice
| 10:15amĀ toĀ 10:35am | Does Your Patient Have Type 1 or Type 2 Diabetes? Or Neither?Lucia M. Novak, MSN, ANP-BC, BC-ADM, CDTC | |
| 10:35amĀ toĀ 10:55am | Other Types of Diabetes Seen in Routine Clinical Practice (MODY, LADA, Others)Miriam Udler, MD, PhD | |
| 10:55amĀ toĀ 11:10am | Break | |
| 11:10amĀ toĀ 11:50am | Q & A and Clinical Cases DiscussionLucia Novak, MSN, ANP-BC, BC-ADM, CDTC andĀ Miriam Udler, MD, PhD |
Management of Diabetes in the Elderly
| 11:50amĀ toĀ 12:10pm | Type 2 Diabetes in the Elderly: What You Need To KnowMedha Munshi, MD | |
| 12:10pmĀ toĀ 12:30pm | A Practical Approach to Anti-Diabetes Medication SelectionMarie McDonnell, MD | |
| 12:30pmĀ toĀ 1:10pm | Q & A and Clinical Cases DiscussionMedha Munshi, MD andĀ Marie McDonnell, MD | |
| 1:10pmĀ toĀ 1:55pm | Break |
Medical Nutrition Management in Diabetes and Obesity
| 1:55pmĀ toĀ 2:15pm | Nutrition Recommendations and GuidelinesLaura Andromalos,Ā MS, RD, CSOWM, CDCES | |
| 2:15pmĀ toĀ 2:35pm | Myths and Truth about the Most Common DietsMelinda D. Maryniuk, MEd, RDN, CDCES, FADA | |
| 2:35pmĀ toĀ 3:15pm | Q & A and Clinical Cases DiscussionLaura Andromalos,Ā MS, RD, CSOWM, CDCES andĀ Melinda D. Maryniuk, MEd, RDN, CDCES, FADA | |
| 3:15pmĀ toĀ 3:45pm | Interactive Breakout Sessions |
Thursday, May 05, 2022
| 9:30amĀ toĀ 9:35am | Welcome, Recap of Day 1, and Description of Day 2 ActivitiesA. Enrique Caballero, MD, Melinda D. Maryniuk, MEd, RDN, CDCES, FADA |
Special Lecture
| 9:35amĀ toĀ 10:15am | Patient Education in Diabetes: What Works and What Does Not WorkMelinda D. Maryniuk, MEd, RDN, CDCES, FADAĀ |
Prescribing Exercise to Patients with Diabetes
| 10:15amĀ toĀ 10:35am | Exercise in Diabetes Care: The Basics on What Works and WhyRoeland Middelbeek, MD, MSc | |
| 10:35amĀ toĀ 10:55am | Exercise Recommendations: Building a Tailored Program Considering Diabetes Status and ComplicationsJacqueline Shahar, MEd, RCEP, CDCES | |
| 10:55amĀ toĀ 11:10am | Break | |
| 11:10amĀ toĀ 11:50am | Q & A and Clinical Cases DiscussionRoeland Middelbeek, MD, MSc andĀ Jacqueline Shahar, MEd, RCEP, CDCES |
Obesity Management: The Controversies
| 11:50amĀ toĀ 12:10pm | Medical Management of Obesity: A Practical ApproachScott Butsch, MD, MSc | |
| 12:10pmĀ toĀ 12:30pm | Surgical Management of Obesity: Is It Really as Good as It Seems?Matthew Hutter, MD,Ā MBA, MPH, FACS | |
| 12:30pmĀ toĀ 1:10pm | Q & A and Clinical Cases DiscussionScott Butsch, MD, MSc and Matthew Hutter, MD,Ā MBA, MPH, FACS | |
| 1:10pmĀ toĀ 1:55pm | Break |
Dyslipidemia Management in the Patient with DM
| 1:55pmĀ toĀ 2:15pm | Current Approach to the Management of LDL Cholesterol as Primary TargetOm Ganda, MD | |
| 2:15pmĀ toĀ 2:35pm | What to Do Once LDL Cholesterol Is at GoalAruna Pradhan, MD, MPH | |
| 2:35pmĀ toĀ 3:15pm | Q & A and Clinical Cases DiscussionOm Ganda, MD andĀ Aruna Pradhan, MD, MPH | |
| 3:15pmĀ toĀ 3:45pm | Interactive Breakout Sessions |
Friday, May 06, 2022
| 9:30amĀ toĀ 9:35am | Welcome, Recap of Day 2 and Description of Day 3 ActivitiesA. Enrique Caballero, MD, and Melinda D. Maryniuk, MEd, RDN, CDCES, FADA |
Special Lecture
| 9:35amĀ toĀ 10:15am | The Road towards Equality in Diabetes CareSherita Golden, MD |
Hypertension Control in the Patient with Diabetes
| 10:15amĀ toĀ 10:35am | Navigating Current Challenges in Hypertension Management for Patients with DiabetesNaomi Fisher, MD | |
| 10:35amĀ toĀ 10:55am | Current Hypertension Drug Management Recommendations for Patients with DiabetesJohn Forman, MD | |
| 10:55amĀ toĀ 11:10am | Break | |
| 11:10amĀ toĀ 11:50am | Q & A and Clinical Cases DiscussionNaomi Fisher, MD and John Forman, MD |
Cardiovascular Risk Reduction
| 11:50amĀ toĀ 12:10pm | Assessing CV Risk in Routine Clinical PracticeJorge Plutzky, MD | |
| 12:10pmĀ toĀ 12:30pm | Current Approach to the Management of CVD and Heart Failure in the Patient with DiabetesChristopher Cannon, MD | |
| 12:30pmĀ toĀ 1:10pm | Q & A and Clinical Cases DiscussionJorge Plutzky, MD and Christopher Cannon, MD | |
| 1:10pmĀ toĀ 1:55pm | Break |
Technology Advances in the Management of Diabetes
| 1:55pmĀ toĀ 2:15pm | Continuous Glucose Monitoring: A 2022 VisionDevin Steenkamp, MD | |
| 2:15pmĀ toĀ 2:35pm | Insulin Pumps, Closing the Loop: Where Do We Stand?Diana Isaacs, PharmD, BCPS, BCACP, BC-ADM, CDCES, FADCES, FCCP | |
| 2:35pmĀ toĀ 3:15pm | Q & A and Clinical Cases DiscussionDevin Steenkamp, MD andĀ Diana Isaacs, PharmD, BCPS, BCACP, BC-ADM, CDCES, FADCES, FCCP | |
| 3:15pmĀ toĀ 3:45pm | Interactive Breakout Sessions |
Saturday, May 07, 2022
| 9:30amĀ toĀ 9:40am | Welcome, Recap of Day 3 and Description of Day 4 ActivitiesA. Enrique Caballero, MD and Melinda D. Maryniuk, MEd, RDN, CDCES, FADA |
Pharmacological Management of Diabetes
| 9:40amĀ toĀ 10:00am | Traditional Medications (Biguanides, SUs, TZDs, Alpha-Glucosidase Inhibitors)David Nathan, MD | |
| 10:00amĀ toĀ 10:20am | Incretin-Based Therapies (DPP-IV Inhibitors and GLP-1 RA)Vanita Aroda, MD | |
| 10:20amĀ toĀ 10:40pm | SGLT-2 InhibitorsSilvio Inzucchi, MD | |
| 10:40amĀ toĀ 11:00am | Insulin TherapyMarie McDonnell, MD | |
| 11:00amĀ toĀ 11:15am | Break | |
| 11:15amĀ toĀ 12:15pm | Q & A and Clinical Cases DiscussionDavid Nathan, MD,Ā Vanita Aroda, MD, Silvio Inzucchi, MD, andĀ Marie McDonnell, MD |
Management of Diabetes in Underserved Communities
| 12:35pmĀ toĀ 12:55pm | Disparities and Inequities in ObesityFatima Cody Stanford, MD, MPH, MPA, MBA,Ā FAAP, FACP, FAHA, FAMWA, FTOS | |
| 12:35pmĀ toĀ 12:55pm | Diabetes, Race, and SocioeconomicsA. Enrique Caballero, MD | |
| 12:55pmĀ toĀ 1:15pm | Q & A and Clinical Cases DiscussionĀ A. Enrique Caballero, MD andĀ Fatima Cody Stanford,Ā MD, MPH, MPA, MBA,Ā FAAP, FACP, FAHA, FAMWA, FTOS | |
| 1:15pmĀ toĀ 2:00pm | Break |
Keynote Lecture
| 2:00pmĀ toĀ 3:00pm | Metabolic-Associated Liver Disease: An Often Forgotten Derangement in the Patient with Diabetes and ObesityScott Isaacs, MD | |
| 3:00pmĀ toĀ 3:20pm | Interactive Breakout Sessions | |
| 3:20pmĀ toĀ 3:45pm | Closing RemarksA. Enrique Caballero, MD and Melinda D. Maryniuk, MEd, RDN, CDCES, FADA |
Release Date : May 4 ā 7, 2022
